Invesaro

Stocks Utilities SONM

NASDAQ · Utilities

DNA X, Inc. (SONM)

It posted a net loss of $8.5M. At June 30, 2026 it held $900K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 19, 2026.

Watch SONM in 60 seconds
Price
$4.35
+11.11% on the day · September 28, 2026
52-week range $2.52 to $16.97
Market cap
$6.5M

What DNA X, Inc. does

DNA X, Inc. is registered with the SEC under industry code SIC 3661 (Telephone & Telegraph Apparatus). Its shares trade on NASDAQ under the ticker SONM.

Revenue and profit by year

Revenue
FY19: $135.7M $135.7M FY19FY19: $116.3M $116.3M FY19FY20: $64M $64M FY20FY21: $54.6M $54.6M FY21FY22: $69.8M $69.8M FY22FY23: $93.6M $93.6M FY23FY24: $58.3M $58.3M FY24
Net income
FY19: $1.3M $1.3M FY19FY19: -$25.8M -$25.8M FY19FY20: -$29.9M -$29.9M FY20FY21: -$38.6M -$38.6M FY21FY22: -$14.1M -$14.1M FY22FY23: -$90K -$90K FY23FY24: -$33.6M -$33.6M FY24FY25: -$20.7M -$20.7M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025n/a-$5.4M-$20.7M-$28.58n/a
2024$58.3M-$3.1M-$33.6M-$128.37-$8.7M
2023$93.6M$513K-$90K-$0.36-$4.1M
2022$69.8M-$14.3M-$14.1M-$8.82-$12.4M
2021$54.6M-$38M-$38.6M-$73.46-$38.5M
2020$64M-$29.3M-$29.9M-$116.67-$10.6M

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What DNA X, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 31, 2026
  2. August 27, 2026
  3. August 19, 2026
    Quarterly report 10-Q · period to June 30, 2026Diluted EPS -$0.92 versus -$14.15.
  4. August 14, 2026
  5. August 13, 2026
  6. August 13, 2026
  7. July 9, 2026
  8. July 2, 2026
  9. June 8, 2026
  10. June 4, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on February 20, 2026. Insider transactions on SEC

Insider trades

What the people running DNA X, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
February 9, 2026 Mulica Michael CActing CEO, Director Received as pay 50,000 - - Form 4
February 9, 2026 Crolius ClaytonChief Financial Officer Received as pay 35,000 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns SONM

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
DNA Holdings Venture Inc.13D, may seek influence with 2 related filers 19.9% 223,201 February 20, 2026
Lytton Laurence W13G, passive 6.8% 100,521 August 13, 2026

Latest filings below 5%: 1 Main Capital Management, LLC 0% (February 17, 2026); Streeterville Capital LLC 0% (January 23, 2026); L1 Capital Global Opportunities Master Fund, Ltd. 0% (November 14, 2025).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

2 insiders reported holding 90,790 shares in total, about $394.9K at the last price.

HolderSharesAs of
Mulica Michael CActing CEO, Director 54,071 February 9, 2026
Crolius ClaytonChief Financial Officer 36,719 February 9, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about SONM

What does DNA X, Inc. do?

DNA X, Inc. is registered with the SEC under industry code SIC 3661 (Telephone & Telegraph Apparatus). Its shares trade on NASDAQ under the ticker SONM.

Is DNA X, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $8.5M.

When did DNA X, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 19, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the other event from August 31, 2026.

Similar companies

Compare SONM with

Compare SONM with any company

Follow SONM

Get an email when DNA X, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow SONM: get an email when it files

Where the numbers come from

Financial figures are the values DNA X, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.